Changhoon Ji
Executive Director AUTOTAC Bio
Seminars
Tuesday 27th October 2026
Highlighting the AUTOTAC Technology as a Bimodal TPD Platform: Development of ATB2005A as a First-in-Class Tau Aggregate Degrader in Clinical Trials
3:10 pm
- Introduction of AutotacBio and the AUTOTAC/ATL platform
- Mechanisms behind ATL-induced, selective autophagy-specific autophagosome biogenesis
- Safety/PK data from Phase 1 clinical trial of ATB2005A
